$BBIO BridgeBio Pharma, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in BridgeBio Pharma, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in BridgeBio Pharma, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in BridgeBio Pharma, Inc. for free.

CIK Number: 0001743881
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: BBIO
Company Address: 421 KIPLING STREET PALO ALTO 94301
Former name: BridgeBio Pharma LLC, date of change: 2018-06-18

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BridgeBio Pharma, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 22 2021BBIOBridgeBio Pharma, ...HOMCY CHARLES JDirectorOption ExerciseA62.6338,8952,435,99438,895
Jun 22 2021BBIOBridgeBio Pharma, ...DANIELS RONALD JDirectorOption ExerciseA62.6338,8952,435,99438,895
Jun 22 2021BBIOBridgeBio Pharma, ...SAUNDERS BRENT LDirectorOption ExerciseA62.6338,8952,435,99438,895
Jun 22 2021BBIOBridgeBio Pharma, ...AGUIAR ERICDirectorOption ExerciseA62.6338,8952,435,99438,895
Feb 18 2021BBIOBridgeBio Pharma, ...STEPHENSON BRIAN CSee RemarksOption ExerciseM0.001,710022,227
Feb 18 2021BBIOBridgeBio Pharma, ...STEPHENSON BRIAN CSee RemarksBuyP62.508,000500,000300,043292 K to 300 K (+2.74 %)
Feb 18 2021BBIOBridgeBio Pharma, ...STEPHENSON BRIAN CSee RemarksPayment of ExerciseF64.9859238,468292,043292.6 K to 292 K (-0.20 %)
Feb 18 2021BBIOBridgeBio Pharma, ...STEPHENSON BRIAN CSee RemarksBuyM0.001,7100292,635290.9 K to 292.6 K (+0.59 %)
Feb 18 2021BBIOBridgeBio Pharma, ...Kumar NeilCEO and PresidentOption ExerciseM0.005,129066,682
Feb 18 2021BBIOBridgeBio Pharma, ...Kumar NeilCEO and PresidentPayment of ExerciseF62.5016,0001,000,0004,711,4254.7 M to 4.7 M (+0.34 %)
Feb 18 2021BBIOBridgeBio Pharma, ...Kumar NeilCEO and PresidentPayment of ExerciseF64.982,139138,9924,695,4254.7 M to 4.7 M (-0.05 %)
Feb 18 2021BBIOBridgeBio Pharma, ...Kumar NeilCEO and PresidentBuyM0.005,12904,697,5644.7 M to 4.7 M (+0.11 %)
Feb 17 2021BBIOBridgeBio Pharma, ...KKR Genetic Disorder L.P.SellS60.473,450,000208,617,36031,060,97134.5 M to 31.1 M (-10.00 %)
Feb 12 2021BBIOBridgeBio Pharma, ...STEPHENSON BRIAN CSee RemarksOption ExerciseA0.0012,449012,449
Feb 12 2021BBIOBridgeBio Pharma, ...STEPHENSON BRIAN CSee RemarksOption ExerciseA68.8773,4405,057,81373,440

View all BridgeBio Pharma, Inc. insider transactions.